11/8/2024  5:25:45 PM Chg. -1.055 Volume Bid6:47:48 PM Ask6:47:48 PM Market Capitalization Dividend Y. P/E Ratio
31.775EUR -3.21% 0
Turnover: 0.000
31.675Bid Size: 948 32.330Ask Size: 928 16.13 bill.EUR - -

Business description

Baxter and the Baxter International Foundation are committed to saving and sustaining lives and creating healthier communities. The company focuses on three core areas including improving access to healthcare; fostering tomorrow’s innovation and serving its communities. Baxter works closely with public and private partners around the world to ensure people have access to the healthcare they need, to develop the next generation of innovators who will lead the way in advancing care, and to create long-lasting impact in Baxter’s communities. The Baxter International Foundation supports initiatives and organizations that make a positive, lasting impact on increasing access to healthcare for the disadvantaged and underserved.
 

Management board & Supervisory board

CEO
Jose (Joe) E. Almeida
Management board
James Borzi, Stacey Eisen, Darren Evans, Gerard (Jerry) Greco, Tobi Karchmer, Heather Knight, Talvis Love, Jeanne Mason, Reazur (Reaz) Rasul, David S. Rosenbloom, Alok Sonig, Brian Stevens, Chris Toth, Steve Wallace, Daniel (Dan) Wolf
Supervisory board
Jose (Joe) E. Almeida, William A. Ampofo II, Michael F. Mahoney, Patricia B. Morrison, Ste hen N. Oesterle, Stephen H. Rusckowski, Nancy M. Schlichting, Brent Shafer, Cath R. Smith, Amy A. Wendell, David S. Wilkes, Peter M. Wilver
 

Company data

Name: Baxter International Inc.
Address: One Baxter Parkway,Deerfield, IL 60015, USA
Phone: +1-224-948-2000
Fax: -
E-mail: -
Internet: www.baxter.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 73.60%
IPO date: 1/13/1978

Investor relations

Name: Clare Trachtman
IR phone: +1-224-948-3020
IR Fax: +1-224-948-4498
IR e-mail: Global_CORP_Investor...ter.com Global_CORP_Investor_Relations@baxter.com

Company calendar

CW 45 | 11/8/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Others
 
50.39%
Vanguard Group
 
11.80%
BlackRock Inc.
 
11.71%
Dodge & Cox
 
5.37%
PZENA INVESTMENT MANAGEMENT LLC
 
4.76%
State Street Corporation
 
4.19%
PRICE T ROWE ASSOCIATES INC MD
 
3.21%
JP Morgan Chase & Co.
 
2.41%
Ameriprise Financial Inc.
 
2.18%
Others
 
3.98%